Does mirabegron relieve ureteric stent-related discomfort? A prospective, randomized, multicentre study.

Bum Sik TaeSeok ChoByung Jo JeonHoon ChoiJae Young ParkSung Yong ChoKeon-Cheol LeeJae Hyun Bae

Published in: BJU international (2018)

The use of 50 mg mirabegron once daily has the potential to reduce ureteric stent-related discomfort. Prospective larger-scale, placebo-controlled studies are warranted to further evaluate the beneficial effects of mirabegron on stent-related symptoms.

Keyphrases

physical activity
placebo controlled
clinical trial
randomized controlled trial
radiation therapy
double blind
depressive symptoms
open label
phase ii